Aditxt (NASDAQ:ADTX) Lowered to “Neutral” at Dawson James

Dawson James downgraded shares of Aditxt (NASDAQ:ADTXGet Rating) from a buy rating to a neutral rating in a report released on Friday, The Fly reports.

Aditxt Stock Down 58.5 %

Aditxt stock opened at $4.31 on Friday. The business has a 50 day moving average of $19.66 and a 200-day moving average of $17.09. Aditxt has a 1 year low of $4.30 and a 1 year high of $136.00.

Aditxt (NASDAQ:ADTXGet Rating) last released its quarterly earnings data on Monday, August 15th. The company reported ($6.50) earnings per share (EPS) for the quarter, missing the consensus estimate of $5.50 by ($12.00). The firm had revenue of $0.22 million during the quarter, compared to the consensus estimate of $10.44 million. On average, sell-side analysts anticipate that Aditxt will post -12 EPS for the current year.

Institutional Trading of Aditxt

An institutional investor recently bought a new position in Aditxt stock. Virtu Financial LLC bought a new stake in shares of Aditxt, Inc. (NASDAQ:ADTXGet Rating) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 495,665 shares of the company’s stock, valued at approximately $71,000. Virtu Financial LLC owned 0.90% of Aditxt as of its most recent filing with the Securities and Exchange Commission. 4.81% of the stock is owned by hedge funds and other institutional investors.

Aditxt Company Profile

(Get Rating)

Aditxt, Inc, a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.

See Also

The Fly logo

Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.